Last CNY30.22 CNY
Change Today 0.00 / 0.00%
Volume 0.0
300347 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/10/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for hangzhou tigermed consulti-a (300347)

Year over year, Hangzhou Tigermed Consulting Co., Ltd. has been able to grow revenues from CNY252.8M CNY to CNY331.5M CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 19.73% to 18.46%. This was a driver that led to a bottom line growth from CNY67.7M CNY to CNY94.1M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2010
CNY
Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
CNY
4 Year
Trend
Revenues120.9191.2252.8331.5
Other Revenues1.92.11.65.0
TOTAL REVENUES122.8193.3254.3336.5
Cost of Goods Sold63.8101.1130.2184.8
GROSS PROFIT59.192.2124.1151.7
Selling General & Admin Expenses, Total21.533.249.961.2
Other Operating Expenses3.14.97.61.5
OTHER OPERATING EXPENSES, TOTAL24.638.157.462.7
OPERATING INCOME34.554.166.789.0
Interest Expense-----0.1-0.1
Interest and Investment Income0.21.56.215.2
NET INTEREST EXPENSE0.21.56.215.1
Currency Exchange Gains (Loss)-0.2-0.4-1.0-2.0
Other Non-Operating Income (Expenses)-0.2-1.2----
EBT, EXCLUDING UNUSUAL ITEMS34.454.072.0102.1
Gain (Loss) on Sale of Assets0.00.00.00.0
Other Unusual Items, Total1.92.96.78.8
Other Unusual Items1.92.96.78.8
EBT, INCLUDING UNUSUAL ITEMS36.357.078.7110.8
Income Tax Expense4.18.910.916.1
Minority Interest in Earnings-0.5-0.3-0.1-0.7
Earnings from Continuing Operations32.248.167.894.7
NET INCOME31.747.867.794.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS31.747.867.794.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS31.747.867.794.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300347:CH CNY30.22 CNY 0.00

300347 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
PAREXEL International Corp $57.51 USD +1.03
WuXi PharmaTech Cayman Inc $34.24 USD +0.10
View Industry Companies
 

Industry Analysis

300347

Industry Average

Valuation 300347 Industry Range
Price/Earnings 57.5x
Price/Sales 12.5x
Price/Book 8.0x
Price/Cash Flow 57.7x
TEV/Sales 11.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANGZHOU TIGERMED CONSULTI-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.